CytoSorbents Corp Announces Quarterly Results for June 30, 2026

What Happened

• CytoSorbents Corporation (CTSO) filed a Form 8-K on August 6, 2026 to furnish a press release announcing its financial results for the quarter ended June 30, 2026. The press release is included as Exhibit 99.1 to the filing.
• The company explicitly stated that the Item 2.02 information is furnished (not “filed”) and therefore is not subject to Section 18 liability of the Exchange Act nor automatically incorporated by reference into other SEC filings.

Key Details

• Filing date: August 6, 2026 (Form 8-K).
• Reporting period: Quarter ended June 30, 2026.
• Exhibit: Press release furnished as Exhibit 99.1.
• Legal note: Item 2.02 disclosure is furnished and not deemed “filed” under the Exchange Act.

Why It Matters

• This filing provides the company’s latest quarterly results — the primary source for updated information on revenue, earnings, cash flow and management commentary that can affect investor decisions and share price.
• Retail investors should review the furnished press release (Exhibit 99.1) and subsequent SEC filings for the detailed financial figures and any forward-looking statements or guidance.